VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10060123 | HBV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
TVIS20001409 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
TVIS20013114 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
TVIS20021268 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
TVIS20013113 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
TVIS20046520 | HPV | ENSG00000101981.12 | protein_coding | F9 | No | No | 2158 | P00740 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | F9 |
---|---|
DrugBank ID | DB09109 |
Drug Name | Turoctocog alfa |
Target ID | BE0000364 |
UniProt ID | P00740 |
Regulation Type | activator |
PubMed IDs | 24797664; 26761578 |
Citations | Ezban M, Vad K, Kjalke M: Turoctocog alfa (NovoEight(R))--from design to clinical proof of concept. Eur J Haematol. 2014 Nov;93(5):369-76. doi: 10.1111/ejh.12366. Epub 2014 May 28.@@Ahmadian H, Hansen EB, Faber JH, Sejergaard L, Karlsson J, Bolt G, Hansen JJ, Thim L: Molecular design and downstream processing of turoctocog alfa (NovoEight), a B-domain truncated factor VIII molecule. Blood Coagul Fibrinolysis. 2016 Jul;27(5):568-75. doi: 10.1097/MBC.0000000000000477. |
Groups | Approved; Investigational |
Direct Classification | Peptides |
SMILES | |
Pathways | |
PharmGKB | |
ChEMBL |